Atorvastatin, Cardiovascular Events, and Disability-free Survival in Older Adults

More on Cardiovascular disease

• Orforglipron matches insulin glargine on cardiovascular safety

  Lancet · 4 Oct 2026

• Social context predicts heart risks despite normal biomarkers

  medRxiv · 4 Oct 2026

• Cumulative non-HDL cholesterol is linked to CVD risk

  Journal of Diabetes and Metabolic Disorders · 4 Oct 2026

• SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs

  Diabetes & Vascular Disease Research · 4 Oct 2026